If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Tomonari Sasaki is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles
Radiotherapy Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Japan Medicine & Life Sciences
radiation therapy Physics & Astronomy
cancer Physics & Astronomy
Brachytherapy Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Esophageal Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

  • 734 Citations
  • 14 h-Index
  • 82 Article
  • 10 Review article
  • 2 Conference contribution
Open Access
Uterine Cervical Neoplasms
Lymph Nodes

Dose evaluation indices for total body irradiation using TomoDirect with different numbers of ports: A comparison with the TomoHelical method

Kasai, Y., Fukuyama, Y., Terashima, H., Nakamura, K. & Sasaki, T., Feb 1 2019, In : Journal of Applied Clinical Medical Physics. 20, 2, p. 129-135 7 p.

Research output: Contribution to journalArticle

Open Access
Whole-Body Irradiation

Japanese structure survey of radiation oncology in 2010

Japanese Society for Radiation Oncology Database Committee, Jan 1 2019, In : Journal of radiation research. 60, 1, p. 80-97 18 p.

Research output: Contribution to journalArticle

Open Access
Radiation Oncology
radiation therapy
Intensity-Modulated Radiotherapy
3 Citations (Scopus)

Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control

Hisano, O., Nonoshita, T., Hirata, H., Sasaki, T., Watanabe, H., wakiyama, H., Ono, M., Saiji, O. & Honda, H., Jan 29 2018, In : Radiation Oncology. 13, 1, 14.

Research output: Contribution to journalArticle

Esophageal Neoplasms
Esophageal Stenosis
Squamous Cell Neoplasms
Endoscopic Mucosal Resection
3 Citations (Scopus)

A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L

Sasaki, T., Seto, T., Yamanaka, T., Kunitake, N., Shimizu, J., Kodaira, T., Nishio, M., Kozuka, T., Takahashi, T., Harada, H., Yoshimura, N., Tsutsumi, S., Kitajima, H., Kataoka, M., Ichinose, Y., Nakagawa, K., Nishimura, Y., Yamamoto, N. & Nakanishi, Y., Sep 11 2018, In : British journal of cancer. 119, 6, p. 675-682 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma